Internal Medicine

Hematologic Malignancies

Questions discussed in this category

Given the data from SWOG 1826 suggesting that Nivo-AVD is likely the preferred regimen for advanced Hodgkin lymphoma patients, are there scenarios where alternative regimens may still be preferred?

When now would you consider regimens such as BV-AVD or BrECADD in advanced stage HL?

1 Answer available

Related Topics in Internal Medicine